Industry of the year Vol.II - 2026

Industry of the year Vol.II - 2026

India Pharma Outlook’s June Edition - 2026: The edition has been prepared after being closely scrutinized by a distinguished panel of judges in­cluding CXOs, analysts, and our editorial board. We recognize their valuable contribution to the ever ex­panding and competitive market and their ability to sustain themselves and emerge as top contestants through their reliable products.

“ARR Molecules continues to strengthen its re­search and development capabilities while investing in advanced analytical systems and process improve­ment initiatives” - ARR Molecules

“CHROMQ provides NABL-traceable calibration support and reference standards that help laborato­ries maintain testing accuracy and audit readiness” – CHROMQ India

“By integrating ethical compliance with pa­tient-focused execution, CRO Pharmatrendz aims to improve both participant retention and overall study quality — two factors that are increasingly critical in complex oncology research environments” - CRO Pharmatrendz

“Dhanvantari Clinical Research Solutions is ac­tively adopting decentralized and patient-friendly trial approaches to improve engagement and reten­tion” - Dhanvantari Clinical Research Solutions

“PHARMANALYTICA’s product opportunity map­ping and competitive intelligence services are de­signed to help companies uncover...

Industry of the year Vol.II - 2026

ARR Molecules ARR Molecules ARR Molecules The global pharmaceutical industry is undergoing a major transformation as pharmaceutical companies increasingly rely on Contract Development and Manufacturing Organizations (CRDMOs) to accelerate drug development.
CHROMQ Instruments CHROMQ Instruments CHROMQ Instruments India’s pharmaceutical industry is entering a new era de¬fined not just by manufacturing scale, but by precision, compliance, and research-driven innovation.
CRO Pharmatrendz CRO Pharmatrendz CRO Pharmatrendz Cancer research is undergoing a major transformation with the rise of precision medicine, biomarker-driven therapies, immuno-oncology, and targeted treatments.
PHARMANALYTICA PHARMANALYTICA PHARMANALYTICA The pharmaceutical industry is entering a new era of transformation, where scientific innovation, regulatory complexity, and evolving patient expectations are redefining the way companies approach growth.
Dhanvantari Clinical Research Solutions Dhanvantari Clinical Research Solutions Dhanvantari Clinical Research Solutions The pharmaceutical and clinical research industry is evolving rapidly as healthcare companies worldwide focus on faster drug development, improved patient outcomes, and technology-driven clinical trials.

© 2026 India Pharma Outlook. All Rights Reserved.